经额窦-颅下入路切除嗅沟脑膜瘤:21例连续病例的手术结果及临床与功能结局
本研究连续纳入21例嗅沟脑膜瘤患者,采用经额窦-颅下入路(TFSSA)手术,肿瘤最大径平均45.9±3.4 mm,平均随访87±7个月。术后MRI均证实肿瘤全切,5年和10年无复发生存率分别为100%和85.7%,手术相关死亡0%、主要并发症4.8%。作者认为TFSSA可实现肿瘤全切、结局良好且并发症率低,可作为治疗大型和巨大型嗅沟脑膜瘤的安全有效入路。
要点
- 21例嗅沟脑膜瘤经TFSSA手术,术后MRI均证实肿瘤全切,手术相关死亡0%、主要并发症4.8%。
- 5年和10年无复发生存率分别为100%和85.7%,平均随访87±7个月。
- 嗅觉丧失风险与脑膜瘤大小显著相关(P<0.001),仅肿瘤最大径小于4 cm者嗅觉保留(4/7,57.1%)。
核心结论
- 作者认为TFSSA可实现肿瘤全切、结局良好且并发症率低,可作为治疗大型和巨大型嗅沟脑膜瘤的安全有效入路。
研究设计与样本
- 连续21例嗅沟脑膜瘤患者经TFSSA手术,肿瘤最大径平均45.9±3.4 mm(范围25-70 mm),手术目标为Simpson I级切除,平均随访87±7个月(范围36-176个月)。
主要发现
- 术后MRI证实全部患者肿瘤全切,5年和10年无复发生存率分别为100%和85.7%。
- 手术相关死亡率为0%,主要并发症率为4.8%。
- 嗅觉丧失风险与脑膜瘤大小显著相关(P<0.001),嗅觉保留仅见于肿瘤最大径小于4 cm者(4/7,57.1%)。
- 随访时简易精神状态检查评分显著改善(P<0.001),无患者认知状况恶化;视觉功能改善7/8(87.5%)。
- 术后卡氏功能状态评分显著提高(P<0.001),格拉斯哥结局评分良好者20例(95.2%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The transfrontal-sinus-subcranial approach (TFSSA) allows for direct exposure and removal of olfactory groove meningiomas (OGMs), without any brain retraction. Compared with other skull base approaches (e.g., fronto-orbitobasal, transbasal, subcranial, fronto-orbitozygomatic, and one-and-half approach), it could offer the same advantages but is less invasive. OBJECTIVE: We report the results in a series of 21 consecutive patients with OGMs and operated on through TFSSA, to propose a viable alternative approach. METHODS: Mean maximum tumor diameter was 45.9 ± 3.4 mm (range, 25-70 mm). The aim of surgery was Simpson grade I removal. Surgical, clinical, and functional outcomes were reported. Mean follow-up was 87 ± 7 months (range, 36-176 months). RESULTS: In all patients, magnetic resonance imaging after surgery confirmed complete tumor removal. The recurrence-free survival rate was 100% and 85.7% at 5 and 10 years, respectively. Surgery-related mortality and major morbidity were 0% and 4.8%, respectively. Risk of anosmia significantly correlates with meningioma size (P < 0.001) and smell sense was preserved only in patients with tumors less than 4 cm in maximum diameter (4/7; 57.1%). A significant improvement of Mini Mental Standard Examination score was recorded at follow-up (P < 0.001) and no patients worsened their cognitive profile. Visual function improved in 7/8 (87.5%). Karnofsky Performance Scale score after surgery significantly increased (P < 0.001). According to the Glasgow Outcome Score, good outcome was achieved in 20 patients (95.2%). CONCLUSIONS: Based on reported results, TFSSA allows complete tumor removal with good outcome and low complication rate. It may be proposed as a safe and effective approach to treat large and giant OGMs.
引用
- Barzaghi LR, Spina A, Gagliardi F, et al. Transfrontal-Sinus-Subcranial Approach to Olfactory Groove Meningiomas: Surgical Results and Clinical and Functional Outcome in a Consecutive Series of 21 Patients. World Neurosurg. 2017. PMID: 28213192. doi:10.1016/j.wneu.2017.02.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。